Uitgebreid zoeken

Relief Therapeutics januari 2023

34 Posts
Pagina: «« 1 2 | Laatste | Omlaag ↓
  3. laatsteloodje 19 maart 2023 10:25

    • laatsteloodje

      Lid sinds: 08 jan 2023

      Laatste bezoek: 17 nov 2024

    • Aanbevelingen

      Ontvangen: 1

      Gegeven: 0

    •    Aantal posts: 25

    ACER

    ACER-801 (Osanetant) werd veilig en goed verdragen, maar er is geen statistisch significante afname van frequentie of ernst van opvliegers bij postmenopauzale vrouwen.
    Daarom wordt de studie tijdelijk gestopt tot alle data daar zijn..
    www.acertx.com/2023/03/17/acer-therap...
  4. laatsteloodje 19 maart 2023 10:28

    • laatsteloodje

      Lid sinds: 08 jan 2023

      Laatste bezoek: 17 nov 2024

    • Aanbevelingen

      Ontvangen: 1

      Gegeven: 0

    •    Aantal posts: 25

    APR

    PKU Golike : Relief presenteert op de Society for Inherited Metabolic Disorders 44th Annual Meeting : betere fysiologische absorptie van een aminozuurpreparaat met verlengde afgifte.
    Preklinisch bewijs voor een beter aminozuurgebruik.
    relieftherapeutics.com/newsblog-detai...
  13. forum rang 10 DeZwarteRidder 3 mei 2023 17:25

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 16 feb 2026

    • Aanbevelingen

      Ontvangen: 28220

      Gegeven: 11860

    •    Aantal posts: 107.866

    Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
    03.05.2023 / 07:00 CET/CEST

    Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares

    GENEVA (May 3, 2023) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief Therapeutics), a biopharmaceutical company committed to delivering innovative treatment options with the potential for transformative outcomes to benefit those suffering from select specialty and rare diseases, today announced the implementation timeline for the reverse split of its ordinary shares, which was approved by shareholders at the Extraordinary General Meeting held on April 28, 2023.

    May 4, 2023: Last trading day of old shares on SIX Swiss Exchange
    May 5, 2023: First trading day of new shares on SIX Swiss Exchange

    As previously communicated, shareholdings will be rounded down to the next lower whole number of new merged shares by applying the 400 to 1 exchange ratio. The resulting fractions will be compensated in cash at a fixed price corresponding to the three-day volume-weighted average price of the Relief Therapeutics share on the SIX Swiss Exchange prior to the reverse split.

    Additional information on the reverse split is provided in a Q&A list available here.

    ABOUT RELIEF THERAPEUTICS

    Relief Therapeutics is a commercial-stage biopharmaceutical company committed to advancing treatment paradigms and delivering improvements in efficacy, safety and convenience to benefit the lives of patients living with select specialty and rare diseases. Relief Therapeutics’ portfolio offers a balanced mix of marketed, revenue-generating products, our proprietary, globally patented Physiomimic™ and TEHCLO™ drug delivery platform technologies and a highly targeted clinical development pipeline consisting of risk-mitigated assets focused in three core therapeutic areas: rare metabolic disorders, rare skin diseases and rare respiratory diseases. In addition, Relief Therapeutics is commercializing several legacy products via licensing and distribution partners. Our mission to provide therapeutic relief to those suffering from rare diseases is being advanced by an international team of well-established, experienced biopharma industry leaders with extensive research, development and rare disease expertise. Relief Therapeutics is headquartered in Geneva, with additional offices in Balerna, Switzerland, Offenbach am Main, Germany and Rome. Relief Therapeutics is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFTF and RLFTY. For more information, please visit our website www.relieftherapeutics.com or follow Relief Therapeutics on LinkedIn and Twitter
  14. forum rang 10 DeZwarteRidder 5 mei 2023 10:11

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 16 feb 2026

    • Aanbevelingen

      Ontvangen: 28220

      Gegeven: 11860

    •    Aantal posts: 107.866

    quote:

    DeZwarteRidder schreef op 3 mei 2023 09:39:

    [...]Ik voorspel een koersstijging van ca 400% en daarna een flinke koersdaling.
    LOL

    Aandeelhouders van dit bedrijfje zijn niet erg slim.....!!!
  15. forum rang 10 DeZwarteRidder 22 mei 2023 09:45

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 16 feb 2026

    • Aanbevelingen

      Ontvangen: 28220

      Gegeven: 11860

    •    Aantal posts: 107.866

    quote:

    DeZwarteRidder schreef op 3 mei 2023 09:39:

    [...]Ik voorspel een koersstijging van ca 400% en daarna een flinke koersdaling.
    Omgerekend is Relief nu nog 1,3 cent waard.
34 Posts
Pagina: «« 1 2 | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursonline.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 467 7.789
AB InBev 3 5.635
Abionyx Pharma 2 29
Ablynx 43 13.357
ABN AMRO 1.583 55.562
ABO-Group 1 29
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 268
Accsys Technologies 24 12.618
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 205
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 15 20.200
Aedifica 3 1.044
Aegon 3.259 324.951
AFC Ajax 538 7.132
Affimed NV 2 6.358
ageas 5.845 109.985
Agfa-Gevaert 15 2.171
Ahold 3.543 74.641
Air France - KLM 1.026 36.007
AIRBUS 1 15
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 469 13.325
Alfen 18 29.571
Allfunds Group 4 1.772
Almunda Professionals (vh Novisource) 651 4.283
Alpha Pro Tech 1 17
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.488 114.842
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.862 253.532
AMG 973 141.461
AMS 3 73
Amsterdam Commodities 307 6.924
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 584
Antonov 22.632 153.607
Aperam 93 15.706
Apollo Alternative Assets 1 17
Apple 5 409
Arcadis 254 9.988
Arcelor Mittal 2.044 322.411
Archos 1 1
Arcona Property Fund 1 305
arGEN-X 18 11.899
Aroundtown SA 1 251
Arrowhead Research 5 9.973
Ascencio 1 39
ASIT biotech 2 697
ASMI 4.109 40.902
ASML 1.769 131.571
ASR Nederland 22 4.622
ATAI Life Sciences 1 7
Atenor Group 1 556
Athlon Group 121 176
Atos 4 3.825
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 36 18.036
Axsome Therapeutics 1 177
Azelis Group 2 28
Azelis Group NV 2 185
Azerion 7 3.857